CME Corp., a specialty distributor of healthcare, laboratory and imaging equipment, announced strategic executive leadership transitions structured to support the company’s continued growth and long-term vision.
Normand Chevrette, CME Corp.’s current CEO, has been appointed executive chairman of the board. In this capacity, Chevrette will focus on corporate governance, stewardship of the company’s employee stock ownership plan and long-term strategic initiatives. KC Meleski, who serves as president, will assume the additional role of CEO. As president and CEO, Meleski will lead CME Corp.’s strategic direction, operational execution and continued expansion into new and emerging areas of healthcare.
Meleski began his career with CME as an account manager for the Greater Boston, Massachusetts area in 2001 moving to national sales manager, vice president of sales and on to president in 2024. With every role, he has directly contributed to the growth of CME’s national footprint and reputation in the healthcare industry as a trusted partner. His commitment to excellence extends beyond CME; since 2018, he has been an active member of the Healthcare Industry Distributors Association, serving on the Acute Care Advisory Council and the board of directors.
The transitions come at a time of continued growth, as the company expands its reach across the healthcare continuum and strengthens its capabilities to meet evolving customer needs.
